MATI RASA
Intro : G
G C
terlalu berlarut kesedihanku
Am G
larut kesendirianku yee karena kamu
G C
terlanjur terlanjur kau patahkanku
Am D Em
hingga aku pun tak mampu yehee buka hatiku
C G
harus ku terima
D Em
dan tetap kuterima
C D
walau pun yang kurasa
chorus :
G C
ku tlah ku tlah mati rasa
Am D G
tak mampu melihat kau butakan segalanya
G C
luka luka yang kurasa
Am D
semakin ku lupakan semakin ku tak bisa
G C
terlanjur terlanjur kau patahkanku
Am D Em
hingga aku pun tak mampu yehee buka hatiku
Solo : C G D Em
C G D
Chorus :
G C
ku tlah ku tlah mati rasa
Am D G
tak mampu melihat kau butakan segalanya
G C
luka luka yang kurasa
Am D Em D/F# G
semakin ku lupakan semakin ku tak bisa
C Am D Em D/F# G
semakin ku lupakan semakin ku tak bisa
C D
semakin ku tak bisa
outro : G
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment